[{"date_published":"2006-05-01T00:00:00Z","page":"557 - 562","quality_controlled":0,"citation":{"apa":"Siegert, S., Schnierle, P., & Schnierle, B. (2006). Novel anti-viral therapy: Drugs that block HIV entry at different target sites. Mini-Reviews in Medicinal Chemistry. Bentham Science Publishers. https://doi.org/10.2174/138955706776876267","ieee":"S. Siegert, P. Schnierle, and B. Schnierle, “Novel anti-viral therapy: Drugs that block HIV entry at different target sites,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 5. Bentham Science Publishers, pp. 557–562, 2006.","ista":"Siegert S, Schnierle P, Schnierle B. 2006. Novel anti-viral therapy: Drugs that block HIV entry at different target sites. Mini-Reviews in Medicinal Chemistry. 6(5), 557–562.","chicago":"Siegert, Sandra, Peter Schnierle, and Barbara Schnierle. “Novel Anti-Viral Therapy: Drugs That Block HIV Entry at Different Target Sites.” Mini-Reviews in Medicinal Chemistry. Bentham Science Publishers, 2006. https://doi.org/10.2174/138955706776876267.","short":"S. Siegert, P. Schnierle, B. Schnierle, Mini-Reviews in Medicinal Chemistry 6 (2006) 557–562.","mla":"Siegert, Sandra, et al. “Novel Anti-Viral Therapy: Drugs That Block HIV Entry at Different Target Sites.” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 5, Bentham Science Publishers, 2006, pp. 557–62, doi:10.2174/138955706776876267."},"publication":"Mini-Reviews in Medicinal Chemistry","uri_base":"https://research-explorer.ista.ac.at","month":"05","day":"01","dc":{"date":["2006"],"source":["Siegert S, Schnierle P, Schnierle B. Novel anti-viral therapy: Drugs that block HIV entry at different target sites. Mini-Reviews in Medicinal Chemistry. 2006;6(5):557-562. doi:10.2174/138955706776876267"],"rights":["info:eu-repo/semantics/closedAccess"],"title":["Novel anti-viral therapy: Drugs that block HIV entry at different target sites"],"publisher":["Bentham Science Publishers"],"relation":["info:eu-repo/semantics/altIdentifier/doi/10.2174/138955706776876267"],"creator":["Sandra Siegert","Schnierle, Peter","Schnierle, Barbara S"],"type":["info:eu-repo/semantics/article","doc-type:article","text","http://purl.org/coar/resource_type/c_6501"],"identifier":["https://research-explorer.ista.ac.at/record/1796"],"description":["Drugs that block the entry of human immunodeficiency virus type 1 (HIV-1) into host cells abrogate the establishment of a productive infection and should ideally diminish the chances of HIV-1 developing resistance. This review will give an overview of the mechanism by which the envelope glycoprotein mediates HIV-1 entry and will summarize current drug developments."]},"volume":6,"dini_type":"doc-type:article","date_created":"2018-12-11T11:54:03Z","date_updated":"2021-01-12T06:53:15Z","author":[{"orcid":"0000-0001-8635-0877","id":"36ACD32E-F248-11E8-B48F-1D18A9856A87","last_name":"Siegert","first_name":"Sandra"},{"last_name":"Schnierle","first_name":"Peter"},{"last_name":"Schnierle","first_name":"Barbara"}],"intvolume":" 6","status":"public","publication_status":"published","_id":"1796","extern":1,"publist_id":"5314","issue":"5","abstract":[{"lang":"eng"}],"type":"journal_article"}]